Federal Circuit Affirms Invalidity Judgment Concerning Zymaxid®/Zymar® (Gatifloxacin) Ophthalmic Solutions 2015-03-20
RMMS Files Supreme Court Amicus Brief on Behalf of GPhA Supporting Specific-Intent-to-Infringe Requirement for Induced Infringement 2015-02-26
RMMS Secures Judgment of Patent Invalidity Following Remand Trial Involving Generic Pulmicort Respules® (Budesonide Inhalation Suspension) 2015-02-13
Federal Circuit Affirms Judgment Of Non-Infringement Involving Generic Trizivir® (Abacavir Sulfate, Lamivudine, and Zidovudine) Tablets 2015-02-12
RMMS Secures Reversal Before Federal Circuit, Invalidating Asserted Patents Concerning Latisse® (bimatoprost) Ophthalmic Solution 2014-07-10
U.S. Court Of Appeals For The Federal Circuit Affirms RMMS's Victory Involving Generic Ibandronate Products 2014-04-11
RMMS Secures Judgment Of Non-Infringement After A Trial Involving Generic Trizivir® (Abacavir Sulfate; Lamivudine; Zidovudine) Tablets 2013-12-17
rmms-secures-judgment-of-patent-invalidity-after-a-trial-involving-gatifloxacin-ocular-formulation-and-method 2013-08-09
.jpg)